Activation of NFBV is involved in transformation of myeloid cells by p210(BCR/ABL)

被引:0
|
作者
Hamdane, M [1 ]
Cordonnier, MH [1 ]
Preudhomme, C [1 ]
DHalluin, JC [1 ]
机构
[1] INSERM,U124,INST RECH CANC,LILLE,FRANCE
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:2909 / 2909
页数:1
相关论文
共 50 条
  • [41] PI 3-kinase activation in BCR/abl-transformed hematopoietic cells does not require interaction of p85 SH2 domains with p210 BCR/abl
    Jain, SK
    Susa, M
    Keeler, ML
    Carlesso, N
    Druker, B
    Varticovski, L
    BLOOD, 1996, 88 (05) : 1542 - 1550
  • [42] EXPRESSION OF P210 BCR/ABL INCREASES HEMATOPOIETIC PROGENITOR-CELL RADIOSENSITIVITY
    SANTUCCI, MA
    ANKLESARIA, P
    LANEUVILLE, P
    DAS, IJ
    SAKAKEENY, MA
    FITZGERALD, TJ
    GREENBERGER, JS
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1993, 26 (05): : 831 - 836
  • [43] The role of ubiquitin-mediated binding in p210 BCR/ABL induced leukemogenesis
    Ru, Chen
    Mahon, Gwen
    Tala, Ilona
    Whitehead, Ian
    CANCER RESEARCH, 2010, 70
  • [44] IMATINIB THERAPY RESPONSE IN CML PATIENTS WITH DIFFERENT BCR/ABL P210 TRANSCRIPTS
    Dmytrenko, I.
    Dyagil, I.
    Minchenko, J.
    Fedorenko, V.
    Shliakhtychenko, T.
    HAEMATOLOGICA, 2013, 98 : 562 - 562
  • [45] P210 BCR-ABL IS COMPLEXED TO P160 BCR AND PH-P53 PROTEINS IN K562 CELLS
    CAMPBELL, ML
    LI, WJ
    ARLINGHAUS, RB
    ONCOGENE, 1990, 5 (05) : 773 - 776
  • [46] Implementing Quantitative BCR-ABL P210 Testing in a Rural Healthcare Setting
    Haydon-Bradford, S.
    Gardner, M.
    Adamson, M.
    Hixson, T.
    Traufler, A.
    Figueroa, D.
    Erickson-Johnson, M.
    Starks, R.
    JOURNAL OF MOLECULAR DIAGNOSTICS, 2023, 25 (11): : S20 - S20
  • [47] SH1 DOMAIN AUTOPHOSPHORYLATION OF P210 BCR ABL IS REQUIRED FOR TRANSFORMATION BUT NOT GROWTH-FACTOR INDEPENDENCE
    PENDERGAST, AM
    GISHIZKY, ML
    HAVLIK, MH
    WITTE, ON
    MOLECULAR AND CELLULAR BIOLOGY, 1993, 13 (03) : 1728 - 1736
  • [48] SHC PHOSPHORYLATION IN MYELOID CELLS IS REGULATED BY GM-CSF, IL-3, STEEL FACTOR AND IS CONSTITUTIVELY INCREASED BY P210(BCR ABL)
    MATSUGUCHI, T
    SALGIA, R
    HALLEK, M
    EDER, M
    DRUKER, B
    ERNST, T
    GRIFFIN, JD
    BLOOD, 1993, 82 (10) : A438 - A438
  • [49] CTLs specific for bcr-abl joining region segment peptides fail to lyse leukemia cells expressing p210 bcr-abl protein
    Chen, W
    Qin, HL
    Reese, VA
    Cheever, MA
    JOURNAL OF IMMUNOTHERAPY, 1998, 21 (04): : 257 - 268
  • [50] P210 Bcr-Abl expression in a primitive multipotent haematopoietic cell line models the development of chronic myeloid leukaemia
    Pierce, A
    Owen-Lynch, PJ
    Spooncer, E
    Dexter, TM
    Whetton, AD
    ONCOGENE, 1998, 17 (05) : 667 - 672